Comprimés de méthotrexate BP 2,5 mg - Fabricant et fournisseur de médicaments oncologiques

Methotrexate Tablet is used to treat breast cancer, skin cancer, neck, and head cancer, rheumatoid arthritis, and other critical condition. Methotrexate is usually available in 2.5mg, 5mg, and 7.5mg presentations. Production capacity is 20 million tablets/month. Our manufacturing facility is WHO-GMP and ISO 9001: 2001 certified.We follow the highest quality standards and our facility follows standard operating procedures recommended by FDA.  We are exporting Methotrexate tablets to more than 40 countries in the region of Latin America, Africa, Cis, Asia, Middle East.  We provide the below regulatory documents to our clients.  1.     Certificate of Analysis (COA) 2.     Method of Analysis (MOA) 3.     Stability Data  4.     Dossiers  5.     Certificate of Pharmaceuticals Product (COPP) / (CPP) 6.     Free Sale Certificate (FSC)  We provide the products on customized manufacturing and third-party manufacturing to our clients. We have earned our clients' confidence by providing faster delivery with the highest standard of quality at affordable rates. Our company is well established in below countriesGuatemala, El Salvador,  Jamaica, Ecuador, Colombia, Papua New Guinea, Venezuela, Trinidad & Tobago, and Guyana.  Our dedicated team of scientists and professionals manufacture and deliver medicines with the highest quality standards. Our delivery team manages the temperature-controlled delivery of the products.   Call us / Whats app us: +91 7567776333, +91 7600055010, or email: nisarg@aetospharma.com, if you are looking for the leading oncology injection manufacturer with faster delivery and the best affordable rates. We respond quickly.